Found 58 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. N/A Extensive research employing diverse omics methodologies has unveiled a var...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE3 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) PHASE1 This is an open-label, single center, non-randomized, phase Ⅱ trial to eval...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of hepatic...
Show More Status
Active Not Recruiting
Location
The first hospital of China medical university
Learn More & Join Trial
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC) PHASE2 This single arm, open label, single center, prospective study was designed ...
Show More Location
Beijing Union Medical College Hospital
Learn More & Join Trial
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma PHASE1 In patients with locally advanced oral squamous cell carcinoma (OSCC), due ...
Show More Location
Shanghai Ninth People's Hospital
Learn More & Join Trial
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria PHASE2 This study was designed to evaluate the effectiveness and safety of mFOLFOX...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial